Search results
BioNTech doubles down on ADC partner MediLink in new $1.8B biobucks pact
Endpoints News· 14 hours agoAs BioNTech’s pipeline tilts back toward oncology, the German biotech is once again tapping a young...
BioNTech pays $25M upfront to strengthen ADC bond with China's MediLink
FierceBiotech· 11 hours agoAfter penning a couple of antibody-drug conjugate (ADC) deals in 2023, BioNTech has returned to MediLink Therapeutics to further pad out its portfolio. This time,
BioNTech (NASDAQ:BNTX) Shares Up 6.1%
ETF DAILY NEWS· 5 days agoBioNTech SE (NASDAQ:BNTX – Get Free Report) shares shot up 6.1% during trading on Wednesday . 657,251 shares were traded during mid-day trading, an increase of 4% from the ...
European Patent Office Sides with Moderna In COVID-19 Vaccine Patent Dispute With Pfizer/BioNTech
Benzinga· 2 weeks agoModerna Inc MRNA has reportedly achieved a significant victory at the European Patent Office (EPO)...
Moderna wins a battle in vaccine patent dispute with Pfizer-BioNTech - The Boston Globe
The Boston Globe· 2 weeks agoModerna said Friday that the European Patent Office has upheld the validity of one of its key...
BioNTech SE (NASDAQ:BNTX) Shares Sold by Robeco Institutional Asset Management B.V.
ETF DAILY NEWS· 3 days agoRobeco Institutional Asset Management B.V. lowered its position in BioNTech SE (NASDAQ:BNTX – Free Report) by 18.8% in the fourth quarter, HoldingsChannel reports. The fund ...
BioNTech (NASDAQ:BNTX) Coverage Initiated by Analysts at Evercore ISI
ETF DAILY NEWS· 2 weeks agoEvercore ISI assumed coverage on shares of BioNTech (NASDAQ:BNTX – Free Report) in a research note issued to investors on Tuesday, Marketbeat reports. TD Cowen boosted their ...
Moderna wins COVID shot patent case against Pfizer-BioNTech in Europe
Reuters via AOL· 2 weeks agoThe company has been locked in a legal battle with Pfizer-BioNTech over their COVID shot Comirnaty...
Investors Buy High Volume of BioNTech Call Options (NASDAQ:BNTX)
ETF DAILY NEWS· 5 days agoBioNTech SE (NASDAQ:BNTX – Get Free Report) was the recipient of some unusual options trading on Wednesday. Traders bought 2,346 call options on the stock. This is an increase ...
MediLink Therapeutics announces a multi-target TMALIN® ADC technology platform license agreement...
The Woonsocket Call· 2 days agoMediLink Therapeutics (Suzhou) Co., Ltd. ("MediLink"), a clinical-stage biotech company, today announces a new strategic collaboration with BioNTech SE (Nasdaq: BNTX, "< ...